What is NRX Pharmaceuticals, Inc. revenue for the last quarter?

NRX Pharmaceuticals, Inc. revenue for the last quarter amounts to 0 USD despite the estimated figure of 0 USD. In the next quarter revenue is expected to reach 0 USD.

How many employees does NRX Pharmaceuticals, Inc. have?

As of Apr 16, 2024, the company has 0 employees. See our rating of the largest employees — is NRX Pharmaceuticals, Inc. on this list?

What is NRX Pharmaceuticals, Inc. EBITDA?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NRX Pharmaceuticals, Inc. EBITDA is ‪−27.58 M‬ USD, and current EBITDA margin is 0%. See more stats in NRX Pharmaceuticals, Inc. financial statements .

NRXP Stock Price and Chart — NASDAQ:NRXP

Overview

Financials News Ideas Technicals Forecast

NRXP chart

Key stats

About NRX Pharmaceuticals, Inc.

NRX Pharmaceuticals, Inc. is a clinical-stage small molecule pharmaceutical company. It engages in developing of novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded on September 18, 2017 and is headquartered in Wilmington, DE.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

‪0.00‬

Ideas

See all ideas

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy